Risperidone
Recent articles
Q&A with W. David Lohr: Antipsychotics, polypharmacy among autistic preschoolers
Hundreds of preschool-aged children in Kentucky began taking antipsychotic medicines in 2012, according to an analysis of Medicaid records. Lohr discusses what it will it take to get them behavioral therapies instead.
Q&A with W. David Lohr: Antipsychotics, polypharmacy among autistic preschoolers
Hundreds of preschool-aged children in Kentucky began taking antipsychotic medicines in 2012, according to an analysis of Medicaid records. Lohr discusses what it will it take to get them behavioral therapies instead.
Prenatal exposure to antipsychotic medication does not increase odds of autism, ADHD
Children born to mothers who take antipsychotic drugs during pregnancy are not more likely to have autism or attention deficit hyperactivity disorder, or to be born preterm or underweight.
Prenatal exposure to antipsychotic medication does not increase odds of autism, ADHD
Children born to mothers who take antipsychotic drugs during pregnancy are not more likely to have autism or attention deficit hyperactivity disorder, or to be born preterm or underweight.
Q&A with Eric Hollander: Cannabis treatments for autism
As cannabis prohibition slowly lifts in the United States, scientists and families in the autism community are increasingly turning to the drug and its constituent compounds to ease autism-related difficulties, including seizures and irritability.
Q&A with Eric Hollander: Cannabis treatments for autism
As cannabis prohibition slowly lifts in the United States, scientists and families in the autism community are increasingly turning to the drug and its constituent compounds to ease autism-related difficulties, including seizures and irritability.
How aripiprazole’s promise for treating autism fell short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.
How aripiprazole’s promise for treating autism fell short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.
Medical ‘home’ programs offer coordinated care for autistic people
A Utah program provides comprehensive care for autistic people across the lifespan and engages families in the decision-making.
Medical ‘home’ programs offer coordinated care for autistic people
A Utah program provides comprehensive care for autistic people across the lifespan and engages families in the decision-making.
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Psychotropic drugs frequently prescribed for autistic people
About one in three autistic people in the United Kingdom is prescribed drugs designed to alter brain function.
Psychotropic drugs frequently prescribed for autistic people
About one in three autistic people in the United Kingdom is prescribed drugs designed to alter brain function.
Revelando los secretos del síndrome X frágil en Colombia
Una remota ciudad colombiana es el hogar del grupo más grande de personas con síndrome de X frágil. Los científicos están aprendiendo de ellos y tratando de ayudar.
Revelando los secretos del síndrome X frágil en Colombia
Una remota ciudad colombiana es el hogar del grupo más grande de personas con síndrome de X frágil. Los científicos están aprendiendo de ellos y tratando de ayudar.
Unlocking the secrets of fragile X in Colombia
A remote Colombian town is home to the world's largest cluster of people with fragile X syndrome. Scientists are learning from them — and trying to help.
Unlocking the secrets of fragile X in Colombia
A remote Colombian town is home to the world's largest cluster of people with fragile X syndrome. Scientists are learning from them — and trying to help.
Rebooting Becky’s brain
An electrical brain implant all but erased the obsessions that had consumed Becky Audette, years after her autism diagnosis. Could similar implants help other people with severe autism?
Rebooting Becky’s brain
An electrical brain implant all but erased the obsessions that had consumed Becky Audette, years after her autism diagnosis. Could similar implants help other people with severe autism?
Explore more from The Transmitter
Switching neural code may solve ongoing face-recognition debate
Face patch cells in macaque monkeys initially respond to images of any object but rapidly transition to attend to faces exclusively, a new study finds.
Switching neural code may solve ongoing face-recognition debate
Face patch cells in macaque monkeys initially respond to images of any object but rapidly transition to attend to faces exclusively, a new study finds.
Liset de la Prida explains how neuron subtypes may control the activity of large neural populations, from manifolds to ripples
De la Prida's work analyzing the varieties of sharp wave ripples in the hippocampus led to her discovery that specific types of neurons control the properties of neural manifolds.
Liset de la Prida explains how neuron subtypes may control the activity of large neural populations, from manifolds to ripples
De la Prida's work analyzing the varieties of sharp wave ripples in the hippocampus led to her discovery that specific types of neurons control the properties of neural manifolds.
At 25, INSAR needs to bring autism scientists together more than ever
As the International Society for Autism Research’s annual meeting in Prague this week celebrates its quarter-century anniversary, its president reflects on the field’s past successes, current challenges and needs for the future
At 25, INSAR needs to bring autism scientists together more than ever
As the International Society for Autism Research’s annual meeting in Prague this week celebrates its quarter-century anniversary, its president reflects on the field’s past successes, current challenges and needs for the future